Tumor treatment for patients with neurofibromatosis type 1 (NF1)

by | Oct 22, 2019 | Gutmann, David, Weber, Jason

— Technology Description

Scientists at the Washington University Neurofibromatosis Center have developed a patented, first-in-class method for treating neurofibromatosis type 1 (NF1) with small molecule inhibitors of targets in the mTOR (mammalian target of rapamycin) signaling pathway. NF1 is a rel…